Marking axillary nodes with 4% carbon microparticle suspension before neoadjuvant chemotherapy improves sentinel node identification rate and axillary staging.

Cleverton Cesar SpautzEduardo Schunemann JuniorLucas Roskamp BudelTereza Cristina Santos CavalcantiMaria Helena LouveiraPlinio Gasperin JuniorLeonardo Paese NissenBernardo Passos SobreiroMaíra Teixeira DóriaCicero Andrade UrbanVinicius Milani Budel

Published in: Journal of surgical oncology (2020)

The association of 4% CMS and PBV is feasible and significantly increased the identification rate of positive LNs. 4% CMS may play an important role as a complementary technique in patients submitted to NAC.

Keyphrases

neoadjuvant chemotherapy
lymph node
sentinel lymph node
locally advanced
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
early stage
peritoneal dialysis
squamous cell carcinoma
bioinformatics analysis
radiation therapy
ultrasound guided
patient reported outcomes